UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 244

Sortiert nach

Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls

European psychiatry, 2012-04, Vol.27 (3), p.206-212

2012

Link zum Volltext

Verfügbarkeit prüfen

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

Psychopharmacologia, 1989, Vol.99 Suppl (S1), p.S28-S31

1989

Link zum Volltext

Verfügbarkeit prüfen

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

EUROPEAN PSYCHIATRY, 2007, Vol.22, p.S5-S6

2007

Link zum Volltext

Verfügbarkeit prüfen

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

Psychopharmacologia, 1994-02, Vol.114 (1), p.31-38

1994

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine transport is regulated differently in patients with schizophrenia

Schizophrenia research, 1999-11, Vol.40 (1), p.37-42

1999

Link zum Volltext

Verfügbarkeit prüfen

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Psychopharmacology, 1995-10, Vol.121 (3), p.309-316

1995

Link zum Volltext

Verfügbarkeit prüfen

Functional characterization of tyrosine transport in fibroblast cells from healthy controls

Neuroscience letters, 2008, Vol.434 (1), p.56-60

2008

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine transport in schizophrenia

Schizophrenia research, 1994-10, Vol.13 (3), p.255-258

1994

Link zum Volltext

Verfügbarkeit prüfen

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Life sciences (1973), 1987-12, Vol.41 (25), p.2749-2757

1987

Link zum Volltext

Verfügbarkeit prüfen

Neuroleptic Treatment of Patients with Schizophrenia Mechanisms of Action and Clinical Significance

British journal of psychiatry, 1994-04, Vol.164 (S23), p.65-70

Wiesel, Frits-axel

1994

Link zum Volltext

Verfügbarkeit prüfen

Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose

Journal of cerebral blood flow and metabolism, 1990-07, Vol.10 (4), p.467

1990

Link zum Volltext

Verfügbarkeit prüfen

Regional brain glucose metabolism: Correlations to biochemical measures and anxiety in patients with schizophrenia

Psychiatry research, 1991-10, Vol.40 (2), p.101-114

1991

Link zum Volltext

Verfügbarkeit prüfen

Metabolic approaches to physiologic subtyping of schizophrenia

Clinical neuropharmacology, 1992, Vol.15 Suppl 1 Pt A, p.26A-27A

Wiesel, F A

1992

Link zum Volltext

Verfügbarkeit prüfen

Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?

Journal of neural transmission. Supplementum, 1992, Vol.37, p.1

Wiesel, F A

1992

Link zum Volltext

Verfügbarkeit prüfen

Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia

Journal of neurology, neurosurgery and psychiatry, 1987-12, Vol.50 (12), p.1655-1664

1987

Link zum Volltext

Verfügbarkeit prüfen

Central D1- and D2-receptor occupancy during antipsychotic drug treatment

Progress in neuro-psychopharmacology & biological psychiatry, 1990, Vol.14 (5), p.759-767

1990

Link zum Volltext

Verfügbarkeit prüfen

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Acta psychiatrica Scandinavica, 1989-08, Vol.80 (S352), p.30-34

1989

Link zum Volltext

Verfügbarkeit prüfen

Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment

Progress in Neuropsychopharmacology & Biological Psychiatry, 1992, Vol.16 (6), p.871-881

Wiesel, Frits-Axel

1992

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients

Acta psychiatrica Scandinavica, 1986-09, Vol.74 (3), p.292-301

1986

Link zum Volltext

Verfügbarkeit prüfen

The Transport of Tyrosine into the Human Brain as Determined with L-[1-11C]Tyrosine and PET

The Journal of nuclear medicine (1978), 1991-11, Vol.32 (11), p.2043-2049

1991

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites

European journal of clinical pharmacology, 1985, Vol.28 (1), p.89-95

1985

Link zum Volltext

Verfügbarkeit prüfen

Neuroleptics and diagnostic heterogeneity in relation to drug evaluation

Psychopharmacology series, 1993, Vol.10, p.124

Wiesel, F A

1993

Link zum Volltext

Verfügbarkeit prüfen

PET studies of dopamine receptors in relation to antipsychotic drug treatment

Clinical neuropharmacology, 1992, Vol.15 Suppl 1 Pt A, p.468A-469A

1992

Link zum Volltext

Verfügbarkeit prüfen

Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients

Life sciences (1973), 1987-08, Vol.41 (7), p.813-816

1987

Link zum Volltext

Verfügbarkeit prüfen

PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose

Acta psychiatrica Scandinavica, 1988-08, Vol.78 (2), p.234-241

1988

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 244

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Humans
(87)
Life Sciences & Biomedicine
(81)
Biological And Medical Sciences
(43)
Male
(40)
Medical Sciences
(36)
Animals
(34)
Medicin Och Hälsovetenskap
(25)
Neurosciences & Neurology
(23)
Adult
(22)
Rats
(22)
Tomography, Emission-Computed
(20)
Schizophrenia
(19)
Neurosciences
(18)
Psychiatry
(18)
Psychology. Psychoanalysis. Psychiatry
(16)
Brain - Metabolism
(15)
Pharmacology & Pharmacy
(15)
Pharmacology. Drug Treatments
(13)
Schizophrenia - Metabolism
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

Tyrosine transport is regulated differently in patients with schizophrenia

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Functional characterization of tyrosine transport in fibroblast cells from healthy controls

Tyrosine transport in schizophrenia

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Neuroleptic Treatment of Patients with Schizophrenia Mechanisms of Action and Clinical Significance

Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose

Regional brain glucose metabolism: Correlations to biochemical measures and anxiety in patients with schizophrenia

Metabolic approaches to physiologic subtyping of schizophrenia

Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?

Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia

Central D1- and D2-receptor occupancy during antipsychotic drug treatment

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients

The Transport of Tyrosine into the Human Brain as Determined with L-[1-11C]Tyrosine and PET

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites

Neuroleptics and diagnostic heterogeneity in relation to drug evaluation

PET studies of dopamine receptors in relation to antipsychotic drug treatment

Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients

PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose

Aktive Filter

Suchergebnisse filtern